BIPAR SCIENCES
BiPar Sciences Inc. is a Brisbane, CA based developer of PARP inhibitors as cancer therapies. BiPar's key experimental product is BSI-201, currently in mid-stage trials for advanced breast cancer, ovarian cancer and other tumors. BiPar has raised around $60 million in VC funding, from firms like [Domain Associates](/financial-organization/domain-associates), [Canaan Partners](/financial-organization/canaan-partners-3), [Vulcan Capital](/financial-organization/vulcan-capital), [PolyTechnos Ven... ture Partners](/financial-organization/polytechnos-venture-partners), [Asset Management Company](/financial-organization/asset-management), and [Quantum Technology Partners](/financial-organization/quantum-technology-partners). It also has raised venture debt from [Lighthouse Capital Partners](/financial-organization/lighthouse-capital-partners). On April 15th, 2009, French drug maker [Sanofi-Aventis S.A.](/organization/sanofi-aventis-2) announced it was acquiring BiPar Sciences for up to $500 million.
BIPAR SCIENCES
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2002-01-01
Address:
Brisbane, California, United States
Country:
United States
Website Url:
http://www.biparsciences.com
Total Employee:
11+
Status:
Active
Contact:
650-635-6050
Total Funding:
74.97 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Nginx Baidu Analytics DNS.COM
Current Employees Featured
Founder
Investors List
Vulcan Capital
Vulcan Capital investment in Series C - BiPar Sciences
Canaan Partners
Canaan Partners investment in Series C - BiPar Sciences
PolyTechnos Venture Partners
PolyTechnos Venture Partners investment in Series C - BiPar Sciences
Asset Management Company
Asset Management Company investment in Series C - BiPar Sciences
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Series C - BiPar Sciences
Domain Associates
Domain Associates investment in Series C - BiPar Sciences
Quantum Technology Partners
Quantum Technology Partners investment in Series C - BiPar Sciences
Sand Hill Angels
Sand Hill Angels investment in Series B - BiPar Sciences
Asset Management Company
Asset Management Company investment in Series B - BiPar Sciences
Sand Hill Angels
Sand Hill Angels investment in Series A - BiPar Sciences
Official Site Inspections
http://www.biparsciences.com
- Host name: 83.229.75.207
- IP address: 83.229.75.207
- Location: Nigeria
- Latitude: 10
- Longitude: 8
- Timezone: Africa/Lagos